Evidence map›Paper›PMID 21865344›Full record

ArticleBlood2011

Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor.

Sanja Sekulovic, Maura Gasparetto, Véronique Lecault, Corinne A Hoesli, David G Kent, Patty Rosten, Adrian Wan, Christy Brookes, Carl L Hansen, James M Piret and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Safety and efficacy of ex vivo expanded CD34Stem cell research & therapy · 2019
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Sanja SekulovicTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada.
Maura Gasparetto
Véronique Lecault
Corinne A Hoesli
David G Kent
Patty Rosten
Adrian Wan
Christy Brookes
Carl L Hansen
James M Piret
Clayton Smith
Connie J Eaves
R Keith Humphries
BC Cancer Agency · CAUpsher-Smith Laboratories (United Kingdom) · GBAstronomy and Space · AUMedical Genetics Center · DEUniversity of British Columbia · CA

Funding

HOXB4 Is An Activator of HSC Self-RenewalR01HL065430 · NHLBI · UNIVERSITY OF MONTREAL · PI SAUVAGEAU, GUY · 2001 to 2009
$2.6M
CIHRNHLBI NIH HHS R01 HL065430NHLBI NIH HHS R01 HL065430-09
6 · The paper itself

Abstract

Achieving high-level expansion of hematopoietic stem cells (HSCs) in vitro will have an important clinical impact in addition to enabling elucidation of their regulation. Here, we couple the ability of engineered NUP98-HOXA10hd expression to stimulate > 1000-fold net expansions of murine HSCs in 10-day cultures initiated with bulk lin(-)Sca-1(+)c-kit(+) cells, with strategies to purify fetal and adult HSCs and analyze their expansion clonally. We find that NUP98-HOXA10hd stimulates comparable expansions of HSCs from both sources at ∼ 60% to 90% unit efficiency in cultures initiated with single cells. Clonally expanded HSCs consistently show balanced long-term contributions to the lymphoid and myeloid lineages without evidence of leukemogenic activity. Although effects on fetal and adult HSCs were indistinguishable, NUP98-HOXA10hd-transduced adult HSCs did not thereby gain a competitive advantage in vivo over freshly isolated fetal HSCs. Live-cell image tracking of single transduced HSCs cultured in a microfluidic device indicates that NUP98-HOXA10hd does not affect their proliferation kinetics, and flow cytometry confirmed the phenotype of normal proliferating HSCs and allowed reisolation of large numbers of expanded HSCs at a purity of 25%. These findings point to the effects of NUP98-HOXA10hd on HSCs in vitro being mediated by promoting self-renewal and set the stage for further dissection of this process.

Indexed as

AnimalsCell Culture TechniquesCell ProliferationCells, CulturedCell SeparationHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHomeodomain ProteinsMiceMice, Inbred C57BLNuclear Pore Complex ProteinsProtein EngineeringRecombinant Fusion ProteinsTranscription FactorsTransduction, GeneticHomeodomain Proteinsnuclear pore complex protein 98Nuclear Pore Complex ProteinsRecombinant Fusion ProteinsTranscription Factors

Identifiers

PMID21865344
PMCPMC3204908
OpenAlexW2092021753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.